Evidence map›Paper›PMID 31713776›Full record

ArticleJournal of assisted reproduction and genetics2019

Preimplantation Genetic Testing for Aneuploidy Improves Clinical, Gestational, and Neonatal Outcomes in Advanced Maternal Age Patients Without Compromising Cumulative Live-Birth Rate.

Laura Sacchi, Elena Albani, Amalia Cesana, Antonella Smeraldi, Valentina Parini, Marco Fabiani, Maurizio Poli, Antonio Capalbo, Paolo Emanuele Levi-Setti

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05442125 (Whether Using DNA Methylome to Select Embryos Can Increase the Live Birth Rate During Assisted Reproductive Technology), which is not on this map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05442125 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Whether Using DNA Methylome to Select Embryos Can Increase the Live Birth Rate During Assisted Reproductive Technology: A Multicenter, Randomized , Open-label Clinical Trial.

TypeinterventionalSponsorShandong UniversityRan2022 to 2025Enrolled1,146ConditionsReproductive Techniques, Assisted, DNA MethylationArmsUsing DNA methylome to select embryos, Using morphologic score to select embryos
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. [Effect of Preimplantation Genetic Testing for Aneuploidies on Live Birth Outcomes and the Influencing Factors in Women of Advanced Maternal Age].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Article
  13. Article
  14. Article
  15. Preimplantation genetic testing for aneuploidy: predictive embryonic factors.Journal of assisted reproduction and genetics · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Laura SacchiDepartment of Gynecology, Division of Gynecology and Reproductive Medicine, Fertility Center, Humanitas Clinical and Research Institute, via Manzoni 56, 20085, Rozzano, MI, Italy.
Elena AlbaniDepartment of Gynecology, Division of Gynecology and Reproductive Medicine, Fertility Center, Humanitas Clinical and Research Institute, via Manzoni 56, 20085, Rozzano, MI, Italy.
Amalia CesanaDepartment of Gynecology, Division of Gynecology and Reproductive Medicine, Fertility Center, Humanitas Clinical and Research Institute, via Manzoni 56, 20085, Rozzano, MI, Italy.
Antonella SmeraldiDepartment of Gynecology, Division of Gynecology and Reproductive Medicine, Fertility Center, Humanitas Clinical and Research Institute, via Manzoni 56, 20085, Rozzano, MI, Italy.
Valentina PariniDepartment of Gynecology, Division of Gynecology and Reproductive Medicine, Fertility Center, Humanitas Clinical and Research Institute, via Manzoni 56, 20085, Rozzano, MI, Italy.
Marco FabianiIgenomix Italy, via E.Fermi 1, 36063, Marostica, VI, Italy.
Maurizio PoliIgenomix Italy, via E.Fermi 1, 36063, Marostica, VI, Italy.
Antonio CapalboIgenomix Italy, via E.Fermi 1, 36063, Marostica, VI, Italy.
Paolo Emanuele Levi-SettiDepartment of Gynecology, Division of Gynecology and Reproductive Medicine, Fertility Center, Humanitas Clinical and Research Institute, via Manzoni 56, 20085, Rozzano, MI, Italy. paolo.levi_setti@humanitas.it.ORCID http://orcid.org/0000-0003-1024-4386
Humanitas University · ITIgenomix · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo report the effects of blastocyst stage aneuploidy testing on clinical, gestational, and neonatal outcomes for patients of advanced maternal age undergoing IVF.

methodsThis is a single-center observational-cohort study with 2 years follow-up. The study includes a total of 2538 couples undergoing 2905 egg collections (control group), 308 (PGT-A), and 106 (drop-out group, consenting for PGT-A but withdrawing due to poor embryological outcome)

resultsCompared with control group, PGT-A showed improved clinical outcomes (live-birth rate per transferred embryo, LBR 40.3% vs 11.0%) and reduced multiple pregnancy rate (MPR, 0% vs 11.1%) and pregnancy loss (PL, 3.6% vs 22.6%). Drop-out group showed the worst clinical outcomes suggesting that abandoning PGT-A due to poor response to ovarian stimulation is not a favorable option. Cytogenetic analysis of product of conceptions and CVS/amniocentesis showed higher aneuploid pregnancy rates for control group regardless of embryo transfer strategy (0%, 17.9%, and 19.9%, for PGT-A, control day 5 and day 3, respectively). Multivariate analysis showed no negative impact of PGT-A-related interventions on cumulative delivery rate (26.3%, 95% CI 21.5-31.6 vs 24.0%, 95% CI 22.5-25.6 for PGT-A and control, respectively) and on neonatal outcomes.

conclusionPGT-A improves clinical outcomes, particularly by reducing pregnancy loss and chromosomally abnormal pregnancy for patients of advanced maternal age, with no major impact on cumulative live-birth rate (CLBR) per egg retrieval.

Indexed as

AneuploidyMaternal AgePreimplantation DiagnosisAbortion, SpontaneousAdultBlastocystComparative Genomic HybridizationEmbryo TransferFemaleFertilization in VitroGenetic TestingHumansPregnancyPregnancy RateAdvanced maternal ageAneuploidyClinical outcomeMiscarriagePreimplantation genetic testing

Identifiers

PMID31713776
PMCPMC6911117
OpenAlexW2985956107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.